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Asthma is a disorder characterized by chronic inflam- 
mation of the lower respiratory tract and often requires 
long-term anti-inflammatory therapy. Inhaled cortico- 
steroids have been found to be very effective in 
controlling the symptoms in asthmatic patients of all ages 
and disease severity (I), and can help to prevent long- 
term irreversible pulmonary damage (2). 
Various delivery devices are currently available for 
inhalation steroid therapy for asthma, including pressurized 
metered-dose inhalers (pMDls), with the possible 
addition of a spacer, dry-powder inhalers (DPls), and 
nebulizers. Treatment success may be compromised in 
certain patients when using pMDls and DPls since they 
are associated with co-ordination and inhalatory 
difficulties, respectively (3,4). As such, nebulization 
appears to be a useful method in children, the elderly, and 
severe or steroid-dependent asthmatics since it allows 
effortless and effective administration of inhaled 
corticosteroids, even at high doses. 
The purpose of the studies reported in this 
supplement was to demonstrate that inhaled cortico- 
steroids administered using nebulization had comparable 
therapeutic effects and safety profiles to those given 
using an MDI in paediatric and adult asthmatics. In the 
studies, a new formulation of beclometasone 
dipropionate (BDP), administered using a nebulizer, was 
compared with BDP given via an MDI (BDP MDI) and 
also with nebulized forms of budesonide and fluticasone 
propionate. Overall, the studies showed that BDP given 
via a nebulizer was therapeutically equivalent to BDP 
MDI, and that both were equally well tolerated. In 
addition, nebulized BDP demonstrated efficacy and safety 
comparable with nebulized forms of both budesonide 
and fluticasone propionate. Importantly, the results 
confirmed that BDP nebulization, at usual therapeutic 
doses, had no significant effect on adrenal axis. These 
results are broadly in agreement with those of previous 
clinical studies. 
In conclusion, nebulization, including jet nebulization, is 
an effective method of administration for inhaled 
corticosteroids in children and adults with asthma of 
varying severity and is a convenient alternative to other 
modes of inhalation. It is a particularly attractive and 
valuable option in cases where drug doses of over 500 
ug are required, and to avoid in certain patients problems 
of poor hand-lung co-ordination that are associated with 
pMDls. 
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